WELCOME TO OUR WORLD
At Oleolive, we don't just dream, we execute. But, we do a lot of dreaming too. One thing that makes our company so special is the ability to chase ideas that seem ridiculous or too hard. We pride ourselves on tackling the tough and exploring areas that are often overlooked or out of vogue. We have an amazing team that is world class in their ability to analyze and move exciting technologies forward. If you are interested in anything we do or sell, I promise that it has been highly scrutinized and not put in place to make a quick buck. We have always put science first and will not compromise on that mission.
Kiley Grant, CEO
Alana Gray, PhD. - COO
Dr. Gray is a USPTO registered patent agent and has a PhD in microbiology and immunology. She manages Oleolive's intellectual property portfolio and most of the day to day operations of the company. Her knack for details and very high standards for quality trickle down into everything Oleolive produces.
Jim Cardelli, PhD. - CTO
Dr. Cardelli is a long-time academic turned entrepreneur. In his words "breaking out of the gilded cage of academia was incredibly difficult but very rewarding". He brings an extensive CV of more than 100 peer reviewed publications and a very large area of expertise to the Oleolive team. His role is to bridge our research to commercialization.
David Coleman, PhD. - CSO
Dr. Coleman oversees all of our research. He plans and decides what data will be the most impactful in our studies. His depth of knowledge is staggering and has a unique ability to juggle many different unrelated projects at the same time.
KDr. El Sayed is a highly credentialed medicinal chemist and the inventor of our original technology. He is also a co-founder of Oleolive. He provides feedback on our projects helping to interpret data and is constantly performing cutting edge research to increase the value of our technologies.
ADr. Amal Kaddoumi is a world expert on Extra Virgin Olive Oil phenolics and has led much of the research related to EVOO polyphenols and their effects in neurodegenerative diseases. She is also a co-founder of Oleolive. She helps to guide the direction of technologies within her domain of expertise and deepens the value of our IP portfolio through her research.